Does direction of results of abstracts submitted to scientific conferences on drug addiction predict full publication? by Vecchi, Simona et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Medical Research 
Methodology
Open Access Correspondence
Does direction of results of abstracts submitted to scientific 
conferences on drug addiction predict full publication?
Simona Vecchi*, Valeria Belleudi, Laura Amato, Marina Davoli and 
Carlo A Perucci
Address: Department of Epidemiology, Italian National Health Service, Local Health Unit Rome E, Via di S. Costanza, 53, 00198 Rome, Italy
Email: Simona Vecchi* - vecchi@asplazio.it; Valeria Belleudi - belleudi@asplazio.it; Laura Amato - amato@asplazio.it; 
Marina Davoli - davoli@asplazio.it; Carlo A Perucci - perucci@asplazio.it
* Corresponding author    
Abstract
Background: Data from scientific literature show that about 63% of abstracts presented at
biomedical conferences will be published in full. Some studies have indicated that full publication is
associated with the direction of results (publication bias). No study has looked into the occurrence
of publication bias in the field of addiction.
Objectives: To investigate whether the significance or direction of results of abstracts presented
at the major international scientific conference on addiction is associated with full publication
Methods: The conference proceedings of the US Annual Meeting of the College on Problems of
Drug Dependence (CPDD), were handsearched for abstracts of randomized controlled trials and
controlled clinical trials that evaluated interventions for prevention, rehabilitation and treatment of
drug addiction in humans (years searched 1993–2002). Data regarding the study designs and
outcomes reported were extracted. Subsequent publication in peer reviewed journals was
searched in MEDLINE and EMBASE databases, as of March 2006.
Results: Out of 5919 abstracts presented, 581 met the inclusion criteria; 359 (62%) conference
abstracts had been published in a broad variety of peer reviewed journals (average time of
publication 2.6 years, SD +/- 1.78). The proportion of published studies was almost the same for
randomized controlled trials (62.4%) and controlled clinical trials (59.5%) while studies that
reported positive results were significantly more likely to be published (74.5%) than those that did
not report statistical results (60.9%.), negative or null results (47.1%) and no results (38.6%),
Abstracts reporting positive results had a significantly higher probability of being published in full,
while abstracts reporting null or negative results were half as likely to be published compared with
positive ones (HR = 0.48; 95%CI 0.30–0.74)
Conclusion: Clinical trials were the minority of abstracts presented at the CPDD; we found
evidence of possible publication bias in the field of addiction, with negative or null results having
half the likelihood of being published than positive ones.
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Background
Dissemination of new scientific research is a critical issue
for researchers. Improving dissemination helps to acceler-
ate research, to enrich education, and to enhance return
on taxpayer investment in research. Usually international
meetings are the first step in this process of dissemination,
when preliminary results are presented, eventually fol-
lowed by full publication of the study in a peer-reviewed
journal. How and when the research is published can be
as significant as the research results themselves, since the
influence of a research article may only be as potent as its
ability to attract an audience of readers.
Data from a systematic review [1] of reports that examine
the rate of full publication of results presented as abstracts
show that 63% of abstracts presented at biomedical meet-
ings will be published in full and that positive study out-
comes are more likely to be subsequently published. This
results in a particular form of bias known as publication
bias; this bias has a particular impact on the quality of sys-
tematic reviews, which involve the comprehensive and
unbiased identification of relevant studies. When this bias
exists, systematic reviews will tend to over-estimate treat-
ment effects.
Another systematic review on the impact of including grey
literature in meta-analyses of healthcare interventions [2]
showed that published trials tend to be larger and show
an overall greater treatment effect than unpublished trials.
This is important particularly in fields where only a few
small trials of a health care intervention have been carried
out.
We set about to investigate the occurrence of publication
bias in the field of addiction, focusing on the direction of
the results and their association with full publication of
abstracts presented at the Annual Meeting of College on
Problems of Drug Dependence (CPDD), one of the most
important international scientific conferences on addic-
tion.
Methods
Identification of the studies
We considered the abstracts presented at the Annual Meet-
ing of College on Problems of Drug Dependence (CPDD),
US, between 1993 and 2002 (N = 5919) which were pub-
lished as supplements in the Drug and Alcohol Depend-
ence journal. Abstracts from other international
conferences were not available. We handsearched and
screened the titles and the abstracts for RCTs and CCTs,
evaluating interventions for prevention, rehabilitation
and treatment of drug addiction in humans. Trials were
classified as RCTs when the randomization was explicitly
defined and as CCTs when it was not.
Exclusion criteria
We excluded abstracts reporting analyses on healthy peo-
ple, pharmacokinetic and toxicity studies, and prelimi-
nary findings reporting the characteristics of the
participants without mention of the allocation groups.
Data extraction
Data was selected by one investigator (SV). For each
selected abstract we collected information on the year of
the meeting, study design, country, substance of abuse
and results. We classified the results of each trial according
to the primary outcome as:
▪ Positive results: statistically significant results (p < 0.05)
in the experimental arm.
▪ Negative or Null results: statistically significant results (p
< 0.05) in the control arm, or not statistically significant
(p = >0.05) results.
▪ Not reported statistical results: abstracts that did not
report statistical significance.
▪ No results: abstracts that do not provide any results.
Table 1: Abstracts of controlled trials published in full, by year.
Conference Year # abstracts identified # abstracts published (%)
1993 59 37 (62.7)
1994 50 34 (68.0)
1995 51 13 (25.5)
1996 27 17 (63.0)
1997 41 26 (63.4)
1998 58 44 (75.9)
1999 60 40 (66.7)
2000 80 48 (60.0)
2001 83 56 (67.5)
2002 72 44 (61.1)
Total 581 359 (62.0)BMC Medical Research Methodology 2009, 9:23 http://www.biomedcentral.com/1471-2288/9/23
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Literature searches
Full-length articles published in peer reviewed journals
were searched in MEDLINE and EMBASE electronic data-
bases from 1992 to March 2006, with no language restric-
tions. The first search criterion was the combination of the
first author's name and/or keywords in the title or
abstract. When this search strategy did not identify any
publications, we added the subsequent authors' names to
the search. We considered the abstract as published if a) at
least one author of the abstract was an author of the full
publication and b) the primary outcome from the abstract
was an outcome in the full manuscript. When a publica-
tion was confirmed, we recorded the journal, month and
year of publication. For journals published in the spring
or fall we assigned the months March or October, respec-
tively.
If the abstract was published more than once, we used the
earliest publication in the analysis. Abstracts published in
full before the presentation at the Conference were
excluded.
Statistical analysis
To evaluate the association between the study findings
and the time interval between submission and publica-
tion, we performed a Kaplan Meier analysis and estimated
hazard ratios of publication. We also examined the asso-
ciation between characteristics of the study (i.e. substance
of abuse) and full publication. Person-time at risk for full
publication was computed as time since presentation of
the abstract to the Conference till time of full publication
or end of follow-up (March 2006).
Results
Out of a total of 5919 abstracts submitted, 581 met the
inclusion criteria; 359 (62%) were subsequently pub-
lished in peer reviewed journals, of which 284 were
reports of RCTs. Table 1 shows the number of abstracts
identified and the percentage of them published in full, by
year.
Of the abstracts published in full, the most common sub-
stances of abuse considered were opioids (127 trials,
35.4%), cocaine (106 trials, 29.5%), not-specified (42 tri-
als, 11.7%), poly-abuse (36 trials, 10%) and cannabis (17
trials, 4.7%). Other substances of abuse (amphetamines,
alcohol, benzodiazepines, caffeine, etc.) were considered
in less than 10% of the studies.
The abstracts were published in 57 journals: 21% in Drug
and Alcohol Dependence, 7.6% in the Journal of Consult-
ing and Clinical Psychology and in Psychopharmacology,
6.3% in the Journal of Substance Abuse Treatment and
Experimental & Clinical Psychopharmacology, and the
remaining 51.2% in a variety of other journals (with < =
3% in a single journal).
Table 2 shows the various study designs and results with
their corresponding publication rates. The proportion of
studies published was split roughly equally for RCTs
Table 3: Rate of full publication by study results
Trials published Median time of publication
(years)
follow-up 100 years Rate Hazard Ratio CI 95%
Positive 120 2.9 6.5 18.5 1.00
Not reported 198 4.2 16.2 12.2 0.70 0.56 0.9
Null or negative 24 5.2 3.0 8.0 0.48 0.30 0.74
No results 17 5.2 2.2 7.7 0.38 0.23 0.64
Table 2: Distribution of the presented abstracts by study design and direction of results
Published
N (%)
Not Published N (%) Total
N
OR CI 95%
Study design
RCT 284 (62.4) 171 (37.5) 455 1.00
CCT 75 (59.5) 51 (40.5) 126 0.9 0.59 1.33
Results
Positive results 120 (74.5) 41 (25.5) 161 1.00
No reported statistical results 198 (61) 127 (39) 325 0.5 0.4 0.8
Negative/null results 24 (47.1) 27 (52.9) 51 0.3 0.2 0.6
No results 17 (38.6) 27 (61.4) 44 0.2 0.1 0.4
Total 359 222 581BMC Medical Research Methodology 2009, 9:23 http://www.biomedcentral.com/1471-2288/9/23
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(62.4%) and CCTs (59.5%) while studies that reported
positive results were significantly more likely to be pub-
lished (74.5%) than those that did not report statistical
results (60.9%), negative or null results (47.1%) and no
results (38.6%). Abstracts reporting positive results had a
significantly higher probability of being published in full,
while abstracts reporting null or negative results were half
as likely to be published compared with positive ones
(Table 3).
The median time lapse until publication was 3.8 years,
The time duration from presentation at the conference to
publication was shorter for trials with positive results than
it was for trials with negative or null results (a median of
2.9 years vs 5.2 years, respectively; p < 0.001) (see Table
3).
The time-dependent probability of publication of studies
based on their results is presented in Figure 1. We found
evidence that the likelihood of publication differed by
study results (Log-rank test p < 0.001).
Discussion and Conclusion
The results of this study demonstrate that RCTs and CCTs
evaluating the effectiveness of interventions for drug
addiction represent a minor proportion of all abstracts
presented at the CPDD Conference. Overall, 62% of
abstracts presented at the CPDD meeting based on ran-
domised or clinically controlled trials were subsequently
published in full in peer reviewed journals. This percent-
age is consistent with other studies on publication rates of
abstracts presented at international conferences in differ-
ent areas of medicine [1,3-8]. No previous studies were
available in the area of addiction.
Our results also indicate that studies with positive find-
ings are more likely to be published. These results are sim-
ilar to those from the study by Scherer et al. [1], who
conducted a meta-analysis combining data from eight
reports that examined full publication of abstracts
describing randomized or controlled trials and found an
association between 'positive' results and full publication.
Moreover, more than half of the abstracts submitted to the
CPDD did not report statistical results.
Conference proceedings do represent a valuable source of
information to be included in systematic reviews, there-
fore there is growing concern about the reliability and
quality of information published in these reports. A
number of studies have highlighted the need for improve-
ments in the reporting of conference abstracts and the
abstracts of journal articles presenting the results of RCTs.
In collaboration with the CONSORT (Consolidated
Standards of Reporting Trials) Group, a checklist of essen-
tial items has been developed that authors should consult
when reporting the main results of an RCT in any journal
or conference abstract [9,10].
The time-dependent probability (Kaplan Meier survival estimates) of publication of studies based on their results Figure 1
The time-dependent probability (Kaplan Meier survival estimates) of publication of studies based on their 
results.
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Some limitations of our study should be taken into
account; we included only abstracts presented at one
international conference because it is considered the most
important international meeting in this field, and because
there are no abstracts electronically and systematically
available from other conferences. This may lead to an
overestimation of the likelihood of publication, particu-
larly for smaller studies or studies with null or negative
results that may be present in less prestigious or local con-
ferences. There is in fact a high probability that even fewer
abstracts from these meetings end up published in full. It
is also expected that the time lapse until publication is
even longer for these abstracts. We may have touched only
the tip of the iceberg of published or unpublished
abstracts.
Moreover, we only searched two electronic databases
(MEDLINE and EMBASE), and did not contact the
authors of the studies for which we were unable to find
the full publication. However, the two main electronic
databases we searched provide 92% of the studies
included in Cochrane reviews published in the area of
drug and alcohol addiction [11]. In addition, our study
does not account for other features of the reports that may
influence time to publication, such as sample size and
methodological quality.
In conclusion, our study confirms that abstracts that
report null or negative results presented at conferences in
the field of addiction are significantly less likely to be pub-
lished than abstracts reporting positive results. If we con-
sider that an additional bias could occur in the acceptance
phase of abstract submission to conferences, possible
publication bias should always be considered when con-
ducting systematic reviews of the effectiveness of interven-
tions for drug dependence in order to avoid biased results.
Making the registries of ongoing trials accessible may be
one way to reduce publication bias. Researchers initiating
randomized controlled trials should register trials to
ensure the availability of trial results, independently of
their full publication. Recently, the World Health Organi-
zation (WHO) launched an International Clinical Trials
Registry Platform (ICTRP) with the mission of ensuring
that a complete view of research is accessible to all those
involved in health care decision making.
Eventually, given that conference proceedings are relevant
for providing updated knowledge to be incorporated into
systematic reviews of the effectiveness of health care inter-
ventions, more efforts should be put into ensuring that
they fairly represent all research, regardless of the direc-
tion of their results.
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